These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9018987)

  • 21. Safety of ingestion of yellow tartrazine by double-blind placebo controlled challenge in 26 atopic adults.
    Pestana S; Moreira M; Olej B
    Allergol Immunopathol (Madr); 2010; 38(3):142-6. PubMed ID: 20106580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intolerance to tartrazine in aspirin-induced asthma: results of a multicenter study.
    Virchow C; Szczeklik A; Bianco S; Schmitz-Schumann M; Juhl E; Robuschi M; Damonte C; Menz G; Serwonska M
    Respiration; 1988; 53(1):20-3. PubMed ID: 3387687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nontartrazine allergy with desipramine.
    Hollander E
    Am J Psychiatry; 1987 Sep; 144(9):1247. PubMed ID: 3631337
    [No Abstract]   [Full Text] [Related]  

  • 24. Sensitivity and tolerance to tartrazine in aspirin-sensitive asthmatics.
    Grzelewska-Rzymowska I; Szmidt M; Kowalski ML; Roźniecki J
    Allergol Immunopathol (Madr); 1986; 14(1):31-6. PubMed ID: 3962814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse reactions to tartrazine.
    Stevenson DD; Simon RA; Lumry WR; Mathison DA
    J Allergy Clin Immunol; 1986 Jul; 78(1 Pt 2):182-91. PubMed ID: 3722646
    [No Abstract]   [Full Text] [Related]  

  • 26. Tartrazine: solid-phase radioimmunoassay studies of an azo dye implicated in allergic reactions (azo dyes and allergy).
    Johnson HM; Smith BG; Kauffman PE
    Proc Soc Exp Biol Med; 1975 Nov; 150(2):278-81. PubMed ID: 1208538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased sensitivity to tartrazine after aspirin desensitization in an asthmatic patient intolerant to both aspirin and tartrazine.
    Michel O; Naeije N; Bracamonte M; Duchateau J; Sergysels R
    Ann Allergy; 1984 May; 52(5):368-70. PubMed ID: 6721262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. More on tartrazine sensitivity.
    Tse CS
    Drug Intell Clin Pharm; 1982; 16(7-8):619-20. PubMed ID: 7105983
    [No Abstract]   [Full Text] [Related]  

  • 29. Adverse reaction to tartrazine in a dipyridamole product.
    Neumann CJ; McCool DL
    Am J Hosp Pharm; 1981 Jun; 38(6):790, 792. PubMed ID: 7246550
    [No Abstract]   [Full Text] [Related]  

  • 30. Possible reaction with NSAIDs and tartrazine.
    Oksas RM
    Drug Intell Clin Pharm; 1985 Jun; 19(6):478-9. PubMed ID: 4006742
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypersensitivity to tartrazine (FD&C Yellow No. 5) and other dyes and additives present in foods and pharmaceutical products.
    Lockey SD
    Ann Allergy; 1977 Mar; 38(3):206-10. PubMed ID: 842907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity to tartrazine.
    Miller K
    Br Med J (Clin Res Ed); 1982 Dec; 285(6355):1597-8. PubMed ID: 6814666
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pseudo-crossreactivity between aspirin and tartrazine].
    Valsecchi R; Tribbia G; Rossi A; Perego GB; Cainelli T
    G Ital Dermatol Venereol; 1988 Apr; 123(4):177-80. PubMed ID: 3182007
    [No Abstract]   [Full Text] [Related]  

  • 34. Tartrazine in oral rehydration solutions.
    Shirole DB
    Indian Pediatr; 1985 Jan; 22(1):76-7. PubMed ID: 4077264
    [No Abstract]   [Full Text] [Related]  

  • 35. [Anaphylaxis to anaesthesic drugs].
    Alaoui-Yazidi A
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S61-10S65. PubMed ID: 17127968
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental and clinical considerations with regard to tartrazine (FD and C yellow No. 5).
    Cordas S
    J Am Osteopath Assoc; 1978 May; 77(9):696-707. PubMed ID: 649453
    [No Abstract]   [Full Text] [Related]  

  • 37. An allergic reaction following intramuscular administration of ketamine and midazolam.
    Boynes SG; Lemak AL; Skradski DM; Cuddy MA
    J Clin Pediatr Dent; 2006; 31(2):77-9. PubMed ID: 17315798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angioedema and urticaria associated with yellow dye in medications.
    Makol GM; Pinnas JL
    Ariz Med; 1980 Feb; 37(2):79-81. PubMed ID: 7369873
    [No Abstract]   [Full Text] [Related]  

  • 39. Aspirin, salicylate, sulfite and tartrazine induced bronchoconstriction. Safe doses and case definition in epidemiological studies.
    Corder EH; Buckley CE
    J Clin Epidemiol; 1995 Oct; 48(10):1269-75. PubMed ID: 7561989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Pharmacist Intervention to Engage Older Adults in Reducing Use of Alprazolam.
    Navy HJ; Weffald L; Delate T; Patel RJ; Dugan JP
    Consult Pharm; 2018 Dec; 33(12):711-722. PubMed ID: 30545435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.